Loading stock data...

Godavari Drugs Limited

BSE: GODAVARI

BSE
84.56 -2.03 (-2.34%)

Prev Close

86.59

Open Price

85.3

Volume

2,829

Today Low / High

84.2 / 86.58

52 WK Low / High

79 / 118.95

Range

80 - 89

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 84.56, reflecting a change of -2.03 (-2.34438%). The expected target range on the BSE is 80 - 89. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.

07 Oct 85.30 -0.87%
06 Oct 87.01 -0.48%
03 Oct 88.00 -0.02%
01 Oct 84.20 2.92%
30 Sep 87.50 -2.72%
29 Sep 88.00 -1.55%
26 Sep 83.99 3.00%
25 Sep 85.00 -0.54%
24 Sep 82.94 0.13%
23 Sep 84.00 -0.85%
22 Sep 85.45 -2.48%
19 Sep 86.00 -0.64%
18 Sep 87.30 -2.18%
17 Sep 87.00 -0.75%
16 Sep 87.75 -1.48%
15 Sep 82.70 5.55%
12 Sep 85.00 -3.20%
11 Sep 81.30 0.16%
10 Sep 81.00 3.20%
09 Sep 84.90 -2.37%

Godavari Drugs Limited Graph

Godavari Drugs Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Godavari Drugs Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 84.56, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 84.56 85.41 76.87 - 93.95
86.25 69.00 - 103.50
87.10 60.97 - 113.23
Bearish Scenario 84.56 83.71 75.34 - 92.09
82.87 66.30 - 99.44
82.02 57.42 - 106.63

Overview of Godavari Drugs Limited

ISIN

INE362C01012

Industry

Medical - Pharmaceuticals

Vol.Avg

3,709

Market Cap

636,779,080

Last Dividend

0

Official Website

Visit Website

IPO Date

DCF Diff

-0.70

DCF

95

Financial Ratios Every Investor Needs

Stock Rating Details for GODAVARI

Metric Value Recommendation
Overall Rating B Neutral
DCF Score 4 Buy
ROE Score 3 Neutral
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 3 Neutral
Price-to-Book (PB) Score 4 Buy

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 113.35 Cr 89.13 Cr 24.22 Cr 0.2136 0.00 Cr 0.00 Cr 9.38 Cr 4.38 Cr 5.82 12.81 Cr 0.0386
2024-03-31 156.71 Cr 120.81 Cr 35.90 Cr 0.2291 0.32 Cr 0.21 Cr 11.47 Cr 5.55 Cr 7.37 12.70 Cr 0.0354
2023-03-31 159.62 Cr 128.06 Cr 31.57 Cr 0.1978 0.28 Cr 0.18 Cr 10.24 Cr 3.79 Cr 5.03 10.81 Cr 0.0237
2022-03-31 161.11 Cr 130.46 Cr 30.65 Cr 0.1903 0.29 Cr 0.19 Cr 9.66 Cr 5.25 Cr 6.97 11.57 Cr 0.0326
2021-03-31 122.67 Cr 96.59 Cr 26.08 Cr 0.2126 0.27 Cr 0.19 Cr 8.60 Cr 4.13 Cr 5.48 10.24 Cr 0.0337

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 2.37 Cr 143.08 Cr 99.73 Cr 43.3461 Cr 61.63 Cr 59.25 Cr 27.94 Cr 62.55 Cr 0.00 Cr 0.00 Cr 1.76 Cr 73.0903 Cr
2024-03-31 2.62 Cr 134.75 Cr 95.79 Cr 38.9661 Cr 57.77 Cr 55.15 Cr 20.65 Cr 45.00 Cr 0.00 Cr 0.00 Cr 0.11 Cr 82.0000 Cr
2023-03-31 0.00 Cr 121.43 Cr 91.80 Cr 33.4172 Cr 57.32 Cr 35.84 Cr 19.86 Cr 33.99 Cr 1.02 Cr 0.00 Cr 0.10 Cr 73.7081 Cr
2022-03-31 0.00 Cr 101.41 Cr 71.78 Cr 29.6314 Cr 23.07 Cr 23.07 Cr 10.03 Cr 26.74 Cr 2.83 Cr 0.72 Cr 0.10 Cr 57.7609 Cr
2021-03-31 0.19 Cr 91.14 Cr 66.75 Cr 24.3861 Cr 30.46 Cr 30.27 Cr 14.65 Cr 23.19 Cr 3.56 Cr 0.00 Cr 0.00 Cr 50.5119 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 6.4640 Cr -19.5121 Cr 12.7985 Cr -13.5341 Cr -0.2496 Cr 2.3733 Cr -20.4893 Cr 4.3800 Cr 12.7278 Cr 0.0000 Cr -7.2909 Cr
2024-03-31 18.4136 Cr -13.2216 Cr -5.6537 Cr 5.2122 Cr -0.4617 Cr 2.6229 Cr -13.2014 Cr 5.5489 Cr -0.7801 Cr 0.0000 Cr -0.7949 Cr
2023-03-31 13.2171 Cr -8.6385 Cr -3.7703 Cr 3.9204 Cr 0.8082 Cr 3.0846 Cr -9.2967 Cr 10.8055 Cr 0.1654 Cr 0.0000 Cr -9.8219 Cr
2022-03-31 11.2298 Cr -4.9707 Cr -5.6210 Cr 5.9847 Cr 0.6381 Cr 2.2764 Cr -5.2451 Cr 5.2453 Cr -2.7077 Cr 0.0000 Cr 4.6163 Cr
2021-03-31 1.3278 Cr -1.2501 Cr 0.1340 Cr -0.3442 Cr 0.2117 Cr 1.6383 Cr -1.6720 Cr 4.1281 Cr 3.3262 Cr 0.0000 Cr 3.1020 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 23.81 Cr 17.14 Cr 6.68 Cr 0.2804 2.29 Cr 1.04 Cr 1.38 2.91 Cr 0.0437
2025-03-31 25.50 Cr 19.67 Cr 5.83 Cr 0.2288 2.44 Cr 0.89 Cr 1.19 3.22 Cr 0.0350
2024-12-31 29.55 Cr 23.09 Cr 6.47 Cr 0.2188 1.93 Cr 0.77 Cr 1.02 2.68 Cr 0.0260
2024-09-30 26.09 Cr 17.57 Cr 8.52 Cr 0.3266 2.32 Cr 1.09 Cr 1.45 2.91 Cr 0.0417
2024-06-30 32.21 Cr 23.41 Cr 8.80 Cr 0.2732 2.68 Cr 1.63 Cr 2.17 4.00 Cr 0.0506

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-06-30 0.00 Cr 0.00 Cr 2.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -43.35 Cr
2025-03-31 2.37 Cr 0.00 Cr 2.37 Cr 43.35 Cr 27.94 Cr 78.76 Cr 62.55 Cr 143.08 Cr 99.73 Cr
2024-12-31 0.00 Cr 0.00 Cr 2.98 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -41.69 Cr
2024-09-30 2.98 Cr 4.71 Cr 7.68 Cr 0.92 Cr 20.22 Cr 73.31 Cr 52.69 Cr 127.49 Cr 85.81 Cr
2024-06-30 0.00 Cr 0.00 Cr 2.62 Cr 0.00 Cr 0.00 Cr 2.62 Cr 0.00 Cr 0.00 Cr -38.97 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 1.04 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 0.89 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 0.77 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 1.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 1.63 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Medical - Pharmaceuticals

Company Name Symbol Price Market Cap Volume
MedPlus Health Services Limited MEDPLUS ₹749.80 ₹89,783,824,011.00 ₹47,767.00

Key Executives

Chief Executive Officer, MD & Executive Director
Mr. Mukund Kakani

Gender: male

Year Born: 1952

Company Secretary & Compliance Officer
Mr. Venkatesh Achanta

Gender: male

Year Born:

Chief Financial Officer & Whole Time Director
Mr. Mohit Jaju

Gender: male

Year Born: 1971

FAQs about Godavari Drugs Limited

Who is the CEO of the company?

The CEO is Mukund Kakani.

What is the current market price of the stock?

The current price is ₹84.56.

What is the 52-week price range?

The range is ₹79-118.95.

What is the market capitalization of the company?

The market capitalization is ₹63.68 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 16.83.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of Godavari Drugs Limited (ISIN: INE362C01012) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹63.68 crores and an average daily volume of 3,709 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.